0
0
nfectious diseases remain one of the most significant public-health challenges across Africa. Although healthcare systems, vaccination programmes, diagnostics and access to treatment have improved substantially in many countries, diseases such as malaria, tuberculosis, HIV/AIDS, cholera and measles continue to cause large numbers of deaths. At the same time, hospitals and healthcare institutions must be prepared for diseases that can suddenly emerge or spread rapidly across borders. The major Ebola outbreak affecting the Democratic Republic of the Congo in 2026 demonstrates how quickly the infectious-disease landscape can change.
The situation is not identical throughout Africa. Disease prevalence depends on climate, population density, vaccination coverage, access to clean water, healthcare capacity, displacement, conflict and many other factors. Nevertheless, hospitals in countries including Nigeria, Ghana, Kenya, Uganda, Tanzania, South Africa, Zambia, Zimbabwe, Botswana, Namibia, Malawi, Mozambique, Angola, the Democratic Republic of the Congo, Republic of the Congo, Rwanda, Burundi, Ethiopia, South Sudan, Sudan, Cameroon, Central African Republic, Chad and Niger regularly encounter infectious diseases that can result in serious illness or death.
For healthcare organisations, knowing that a disease exists is not enough. Doctors, nurses, laboratory employees, infection-prevention specialists and emergency departments need rapid access to information about transmission routes, incubation periods, symptoms, diagnostic considerations, isolation requirements, occupational exposure and appropriate precautions. This is one of the reasons why a structured infectious-disease and pathogen database can become an important part of modern healthcare preparedness.
Africa Continues to Carry a Major Infectious-Disease Burden
Malaria remains perhaps the clearest example of the continuing burden. According to the latest World Health Organization figures, the WHO African Region accounted for approximately 95% of global malaria cases and malaria deaths in 2024. Around 579,000 malaria deaths occurred in the region, with children under five representing approximately three quarters of those deaths. Nigeria alone accounted for almost one third of malaria deaths in the African Region, followed by the Democratic Republic of the Congo and Niger.
This means malaria remains an everyday clinical reality in many hospitals rather than an exceptional infectious-disease event. Nigeria, the Democratic Republic of the Congo, Niger, Tanzania and many countries throughout sub-Saharan Africa continue to experience substantial malaria transmission.
Tuberculosis represents another enormous challenge. WHO reported in March 2026 that approximately 378,000 people died from TB in the African Region in 2024 and around 2.7 million people developed the disease. Although TB mortality has fallen substantially since 2015, the disease continues to kill approximately one person every 83 seconds in the WHO African Region. Drug-resistant tuberculosis adds another layer of complexity because diagnosis, isolation, treatment and occupational-health measures can be considerably more demanding.
Countries such as South Africa, Mozambique, Tanzania and Zambia have made significant progress, but TB remains a major concern throughout eastern, southern, central and western Africa. The relationship between tuberculosis and HIV is especially important. TB remains a leading cause of death among people living with HIV, meaning healthcare workers frequently need to consider multiple infections and vulnerabilities simultaneously.
HIV/AIDS itself also continues to cause significant mortality. UNAIDS estimates that approximately 570,000 people worldwide died from AIDS-related illnesses during 2025, with sub-Saharan Africa continuing to carry a large proportion of the global HIV burden. Eastern and southern Africa, including South Africa, Mozambique, Zimbabwe, Zambia, Malawi, Tanzania, Uganda and Kenya, remain particularly important regions for HIV prevention, diagnosis and long-term treatment. Western and central African countries including Nigeria, Cameroon, Ghana and the Democratic Republic of the Congo also continue to manage substantial HIV populations.
Cholera and Ebola Show How Quickly the Situation Can Change
Alongside these long-established diseases, African healthcare organisations must constantly prepare for outbreaks.
Cholera provides a particularly clear example. During the first six months of 2026, WHO reported more than 90,000 cholera cases and 1,528 deaths in its African Region. The Democratic Republic of the Congo recorded the largest number of deaths, followed by Nigeria and Angola. Significant outbreaks or cases were also reported in South Sudan, Mozambique, Malawi, Burundi, Cameroon, Central African Republic, Chad, Republic of the Congo, Ethiopia, Tanzania, Zambia and other countries.
Cholera can become especially dangerous when conflict, displacement, flooding, poor sanitation or limited healthcare access occur simultaneously. For hospitals and clinics this means preparedness involves much more than recognising diarrhoea. Staff may need immediate information about transmission, infection prevention, fluid management, specimen handling, environmental cleaning and outbreak control.
The major 2026 Ebola outbreak in the Democratic Republic of the Congo demonstrates the other extreme of infectious-disease preparedness. The outbreak is caused by Bundibugyo virus, a species of Ebola virus. By 26 August 2026, WHO reported 5,815 confirmed cases and 2,788 deaths, overwhelmingly in the Democratic Republic of the Congo. Uganda had previously recorded 20 confirmed cases, including two deaths. The outbreak has been classified as a public health emergency of international concern.
For healthcare institutions, such an outbreak creates immediate questions. How is the pathogen transmitted? What is the incubation period? Which symptoms should trigger isolation? What personal protective equipment is appropriate? How should specimens be handled? What are the occupational risks to healthcare workers? What environmental disinfection measures are necessary? These questions cannot be researched from scratch only after a potentially infected patient arrives.
Measles is another disease that should not be underestimated. Despite the existence of an effective vaccine, WHO estimates that approximately 95,000 people died globally from measles in 2024, mainly unvaccinated or under-vaccinated children. Measles remains common in parts of Africa, particularly where vaccination coverage is insufficient or healthcare systems have been disrupted by conflict or humanitarian emergencies.
Hospitals Need Information Before an Emergency Happens
A hospital normally has protocols for infection prevention, occupational exposure and isolation. However, individual procedures cannot realistically contain comprehensive information on every bacterium, virus, parasite, fungus or infectious disease that personnel may encounter.
This is where a dedicated pathogen database becomes valuable.
A structured database can provide a central reference source for infection-prevention teams, physicians, nurses, laboratory departments, emergency departments, occupational-health professionals and hospital management. Instead of searching through numerous websites and documents whenever an unfamiliar disease is suspected, staff can consult a structured information source and quickly identify the characteristics of the pathogen and the hazards associated with exposure.
The value becomes even greater in African healthcare environments because the disease spectrum can be exceptionally broad. A hospital may routinely treat malaria, HIV and tuberculosis while simultaneously needing to recognise cholera, meningitis or measles outbreaks. A patient returning from another region may present with an entirely different infectious disease. Healthcare workers can also be among the first groups exposed during an emerging outbreak, as has repeatedly occurred during Ebola epidemics.
SafetyNet Africa therefore offers the Infectious Diseases & Pathogen Database as a professional reference resource for organisations that need structured information on infectious diseases and pathogens.
For hospitals, clinics, laboratories, occupational-health departments and other healthcare organisations, such a database should not replace clinical guidelines, national health authorities or WHO outbreak information. Its role is different. It provides an organised knowledge base that helps professionals understand diseases, recognise hazards and prepare appropriate procedures before an incident occurs.
From Clinical Knowledge to Organisational Preparedness
The lesson from Africa’s current infectious-disease situation is that healthcare preparedness cannot focus on only one disease. Malaria may cause hundreds of thousands of deaths over a year, while cholera can suddenly overwhelm communities within weeks. Tuberculosis develops more slowly but creates major long-term clinical and occupational-health challenges. Measles can return where vaccination coverage decreases. Ebola can transform an initially unexplained cluster of illness into an international health emergency.
Hospitals therefore need both specialist clinical expertise and accessible institutional knowledge.
A comprehensive infectious-disease database can support risk assessments, infection-prevention planning, laboratory safety, training, emergency preparedness and the development of internal procedures. It can also help healthcare organisations identify knowledge gaps before staff encounter an unfamiliar pathogen.
For African healthcare institutions, this is becoming increasingly important. Infectious diseases do not respect hospital walls, provincial borders or national boundaries. Climate change, international travel, urbanisation, migration, conflict and changing disease patterns make rapid access to reliable pathogen information increasingly valuable.
The SafetyNet Africa Infectious Diseases & Pathogen Database can therefore be viewed not simply as a database, but as part of a broader preparedness strategy. Knowing which diseases are present today is important. Having the information needed to understand the disease that may arrive tomorrow is equally important.
